The Patent Finder

Terms ending in 2037

Cellectis

Every in-force patent on Cellectis's record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 10,752,670ANTI-GD3 Specific Chimeric Antigen Receptors for Cancer Immunotherapy
In force
 · High confidence
CellectisIn forceHigh confidence
US 10,259,876Chimeric Antigen Receptors Targeting Epidermal Growth Factor Receptor Variant III
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 10,550,402Modifying Soybean Oil Composition Through Targeted Knockout of the FAD3A/B/C Genes
In force
 · High confidence
CellectisIn forceHigh confidence
US 11,987,639Trophoblast Glycoprotein (5T4, TPBG) Specific Chimeric Antigen Receptors for Cancer Immunotherapy
In force
 · High confidence
CellectisIn forceHigh confidence
US 12,171,820Method for Generating Immune Cells Resistant to Arginine And/Or Tryptophan Depleted Microenvironment
In force
 · High confidence
CellectisIn forceHigh confidence
US 10,894,093A Method of Engineering Drug-Specific Hypersensitive T-Cells for Immunotherapy by Gene Inactivation
In force
 · High confidence
CellectisIn forceHigh confidence
US 11,674,155Sequential Gene Editing in Primary Immune Cells
In force
 · High confidence
CellectisIn forceHigh confidence
US 11,466,291Sequential Gene Editing in Primary Immune Cells
In force
 · High confidence
CellectisIn forceHigh confidence
US 12,391,933Targeted Gene Insertion for Improved Immune Cells Therapy
In force
 · High confidence
CellectisIn forceHigh confidence
US 10,988,542Chimeric Antigen Receptors with Integrated Controllable Functions
In force
 · High confidence
CellectisIn forceHigh confidence
1 more term end in 2037 · Pro
10 of 11 patents shown. Soonest term end first, then patent number.
Pro members see all 11.
Upgrade to Pro
10 of these are in force and held by Cellectis.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited